What is the brand name for immediate‑release oxycodone (oxycodone hydrochloride)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brand Names for Immediate-Release Oxycodone

Roxicodone is the primary brand name for immediate-release oxycodone hydrochloride. 1

Available Brand Names and Formulations

Single-Entity Immediate-Release Oxycodone

  • Roxicodone: The most commonly referenced brand name for IR oxycodone hydrochloride in clinical guidelines 1, 2
  • OxyNorm: Available as capsules and oral solution for immediate-release formulation 3
  • Oxecta: An abuse-deterrent formulation of IR oxycodone using Aversion Technology 2
  • RoxyBond: A novel abuse-deterrent immediate-release formulation 4

Combination Products with Acetaminophen

  • Percocet: Oxycodone combined with acetaminophen (maximum 325 mg acetaminophen per tablet) 1
  • Percolone: Another oxycodone/acetaminophen combination product 1

Combination Products with Other Agents

  • Percodan: Oxycodone combination product 1

Important Clinical Distinctions

Immediate-Release vs Extended-Release

  • IR formulations (Roxicodone, OxyNorm) have onset within 10-30 minutes and duration of 3-6 hours 5, 3
  • ER formulations (OxyContin) have onset around 1 hour and duration of 10-12 hours, and should NOT be used for acute pain 1, 5

Prescribing Considerations

  • The CDC recommends initiating opioid therapy with immediate-release formulations rather than extended-release products 5
  • When prescribing, specify both the release mechanism (IR vs ER) and dose to avoid confusion 5
  • IR oxycodone is a Schedule II controlled substance 1
  • Initial dosing for IR oxycodone is typically 5-15 mg every 4-6 hours as needed 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oxycodone: a pharmacological and clinical review.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2007

Guideline

Oxycodone Formulations and Prescribing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.